INTERNATIONAL BIOTECHNOLOGY TRUST PLC

13F Filings History

Latest 13F report
Q3 2023 - Nov 14, 2023
Value $
$297M
Signature - Title
James Costine - Authorised Signatory
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by INTERNATIONAL BIOTECHNOLOGY TRUST PLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. INTERNATIONAL BIOTECHNOLOGY TRUST PLC reported 65 stock holdings with total value $297M as of Q3 2023. Top holdings included AMGN, INCY, GILD, ITCI, and BMRN.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2023 65 $297M +$76.1M -$91.5M -$15.4M AMGN, INCY, GILD, ITCI, BMRN 13F-HR 11/14/2023, 06:16 AM
Q2 2023 61 $329M +$109M -$140M -$30.4M AMGN, INCY, HRMY, REGN, SUPN 13F-HR 8/8/2023, 06:30 AM
Q1 2023 64 $358M +$90.3M -$59.7M +$30.7M SGEN, AMGN, INCY, HRMY, ALKS 13F-HR 5/18/2023, 07:12 AM
Q4 2022 63 $324M +$35.6M -$60.6M -$25M HZNP, SGEN, INCY, ALKS, HRMY 13F-HR 2/1/2023, 06:16 AM
Q3 2022 66 $312M +$64.2M -$57.2K +$64.2M HZNP, SGEN, INCY, ALKS, GILD 13F-HR 11/8/2022, 09:53 AM
Q2 2022 78 $879K $0 $0 SUPN, HZNP, ZLAB, GMAB, ALKS 13F-HR 8/16/2022, 09:56 AM
Q1 2022 70 $20.3M $0 $0 HZNP, KDNY, UTHR, APLS, ORIC 13F-HR 5/20/2022, 09:37 AM
Q4 2021 73 $439M +$96.1M -$55.1M +$41M AMGN, NBIX, ALNY, INCY, GILD 13F-HR 2/15/2022, 06:30 AM
Q3 2021 69 $408M +$122M -$91.8M +$30.7M GILD, NBIX, HZNP, AMGN, BHVN 13F-HR 11/12/2021, 09:47 AM
Q2 2021 67 $375M +$89.2M -$90.4M -$1.25M GILD, ALNY, SGEN, HZNP, REGN 13F-HR 8/11/2021, 06:54 AM
Q1 2021 56 $378M +$120M -$77.9M +$42.3M HZNP, GILD, REGN, NBIX, EXEL 13F-HR 5/17/2021, 09:46 AM
Q4 2020 52 $366M +$86M -$56.2M +$29.8M HZNP, ACAD, VRTX, BMRN, PTCT 13F-HR 2/19/2021, 10:31 AM
Q3 2020 53 $310M +$54.3M -$67.3M -$13M HZNP, NBIX, GILD, ACAD, BMRN 13F-HR 12/1/2020, 08:37 AM
Q2 2020 53 $301M +$53.1M -$27.6M +$25.5M HZNP, BMRN, GILD, VRTX, IMMU 13F-HR 7/14/2020, 03:47 PM
Q1 2020 56 $219M +$39.3M -$68.5M -$29.2M VRTX, GILD, BIIB, BMRN, ACAD 13F-HR 5/18/2020, 06:07 AM
Q4 2019 63 $278M +$69.2M -$49.1M +$20M VRTX, GILD, AMGN, ACAD, NBIX 13F-HR 5/18/2020, 06:05 AM
Q3 2019 58 $216M +$21.1M -$39.4M -$18.3M GILD, CELG, VRTX, NBIX, AMGN 13F-HR 11/14/2019, 06:10 AM
Q2 2019 64 $270M +$70.8M -$64.4M +$6.4M GILD, VRTX, NBIX, CELG, ALXN 13F-HR 8/14/2019, 06:30 AM
Q1 2019 62 $271M +$50.5M $0 +$50.5M CELG, GILD, REGN, STML, ALXN 13F-HR 5/14/2019, 11:22 AM
Q4 2018 45 $0 $0 $0 13F-HR 2/14/2019, 10:00 AM
Q3 2018 51 $2K $0 $0 RSLS Restatement 11/14/2018, 03:15 PM
Q2 2018 54 $260M +$46.6M -$56.3M -$9.69M NBIX, CELG, VRTX, ILMN, ARRY 13F-HR 8/13/2018, 06:07 AM
Q1 2018 63 $256M +$60.4M -$68.9M -$8.53M CELG, SHPG, ARRY, NBIX, BIIB 13F-HR 5/15/2018, 08:00 AM
Q4 2017 65 $284M +$68.2M -$34M +$34.2M BIIB, CELG, REGN, NKTR, EXEL 13F-HR 3/2/2018, 04:05 PM
Q3 2017 56 $257M +$57.3M -$78.3M -$21M CELG, BIIB, REGN, VRTX, ALXN 13F-HR 3/2/2018, 04:11 PM
Q2 2017 60 $263M +$55M -$64.6M -$9.6M REGN, CELG, VRTX, BIIB, ALXN 13F-HR 3/2/2018, 04:06 PM
Q1 2017 60 $261M +$73.1M -$52M +$21.1M CELG, BIIB, REGN, INCY, ALXN 13F-HR 3/2/2018, 04:05 PM
Q4 2016 49 $222M $0 $0 CELG, BIIB, ALXN, SHPG, TSRO 13F-HR 3/2/2018, 04:06 PM